Opportunity Information: Apply for PAR 25 181

The National Institute of Mental Health (NIMH), within the National Institutes of Health (NIH), is offering a discretionary grant opportunity titled Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required), Funding Opportunity Number PAR 25-181 (CFDA 93.242). This notice of funding opportunity sits within NIMH's clinical trials pipeline and is designed to support pilot-stage clinical trial work that moves promising psychosocial intervention ideas toward stronger evidence and clearer mechanisms. The overall aim is to accelerate translation from basic and mechanistic research in behavioral, cognitive, affective, and neuropsychological science into practical preventive or therapeutic psychosocial interventions for mental disorders.

A central feature of this opportunity is NIMH's experimental therapeutics approach. In practical terms, applicants are expected to define a measurable intervention target (for example, a cognitive process, emotion regulation mechanism, social process, learning mechanism, or other modifiable factor believed to drive symptoms or impairment), build or refine a psychosocial intervention specifically intended to engage that target, and then test whether the intervention actually engages it in people. Beyond simply showing symptom improvement, the program emphasizes demonstrating target engagement and examining whether changes in the target are associated with changes in clinically meaningful outcomes. The intent is to fund work that can tell a clear story about what the intervention is changing and why that change matters clinically, rather than only whether the intervention "works" on average.

The R33 mechanism will provide up to three years of support. Within that timeframe, the funded work is expected to (1) replicate target engagement that has been shown in prior studies and (2) test the association between target engagement and changes in clinical outcome(s). This makes the opportunity particularly relevant for teams that already have preliminary evidence suggesting a specific psychosocial strategy can move a hypothesized mechanism, and who are ready to test that mechanism-outcome link in a pilot clinical trial that is appropriately designed, measured, and analyzed.

Because this is an R33 clinical trial required opportunity, the proposed project must include a clinical trial component rather than being purely observational or preclinical. While the announcement language stresses pilot research, it is oriented toward rigorous early-stage testing of a novel psychosocial intervention and/or a novel target, with careful measurement of the putative mechanism and clinically relevant endpoints. Applicants should expect that study design decisions (such as comparison conditions, timing and frequency of assessments, fidelity monitoring, and analytic plans) will be scrutinized for how well they can answer the mechanistic questions about target engagement and its relationship to outcomes.

Eligibility is broad and includes many organization types. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations that are not federally recognized tribal governments. The program also allows applications from public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education), for-profit organizations other than small businesses, and small businesses. In addition, the opportunity explicitly highlights other eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This broad eligibility signals NIMH's interest in encouraging diverse institutional participation and potentially supporting intervention development and testing in a wide range of real-world settings and populations.

Key administrative details include an original closing date of 2027-10-15 and a creation date of 2024-11-26. The listing does not specify an award ceiling or expected number of awards in the source data provided, so applicants would need to consult the full NOFO for budget guidance, application due date structure, and any institute-specific limits or expectations. Overall, the opportunity is best understood as targeted support for mechanism-driven psychosocial intervention development and pilot clinical trial testing, with a strong preference for proposals that can convincingly measure and replicate target engagement and directly connect that engagement to meaningful clinical change.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2024-11-26.
  • Applicants must submit their applications by 2027-10-15.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 25 181

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: UMRS Forest Resources Inventory and Analysis

Previous opportunity: Implement and sustain a comprehensive response to HIV and technical assistance to strengthen the capacity of regional authorities in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 25 181

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 25 181) also looked into and applied for these:

Funding Opportunity
Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 25 192

Funding Number: PAR 25 192
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) Apply for PAR 25 193

Funding Number: PAR 25 193
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PA 25 245

Funding Number: PA 25 245
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) Apply for PA 25 163

Funding Number: PA 25 163
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 24 049

Funding Number: RFA AG 24 049
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 25 188

Funding Number: PAR 25 188
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed Apply for RFA RM 24 012

Funding Number: RFA RM 24 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) Apply for PAR 25 216

Funding Number: PAR 25 216
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) Apply for PAR 25 215

Funding Number: PAR 25 215
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) Apply for PAR 25 271

Funding Number: PAR 25 271
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Apply for PAR 25 270

Funding Number: PAR 25 270
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,050,000
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) Apply for PAR 25 300

Funding Number: PAR 25 300
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) Apply for PAR 25 269

Funding Number: PAR 25 269
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
PEPFAR Community Led Monitoring (CLM)-Zambia Apply for PCLM 2025

Funding Number: PCLM 2025
Agency: U.S. Mission to Zambia
Category: Health
Funding Amount: $115,000
USAID SUstaining Control of the HIV Epidemic through quality Services, resilient Systems, and Community Outreach (SUCESSO) _ Sofala & Niassa Apply for 72065625RFA00002

Funding Number: 72065625RFA00002
Agency: Mozambique USAID-Maputo
Category: Health
Funding Amount: $77,500,000
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) Apply for PAR 25 251

Funding Number: PAR 25 251
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
USAID Sustaining Control of the HIV Epidemic through quality Services, resilient systems, and Community Outreach (SUCESSO) - Tete & Manica Apply for 72065625RFA00005

Funding Number: 72065625RFA00005
Agency: Mozambique USAID-Maputo
Category: Health
Funding Amount: $77,500,000
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) Apply for PAR 25 310

Funding Number: PAR 25 310
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 25 297

Funding Number: PAR 25 297
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) Apply for PAR 25 026

Funding Number: PAR 25 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 181", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: